NCT00597636
Active, not recruiting
Not Applicable
Genetic Susceptibility to Lung Cancer in Never Smokers
ConditionsLung Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 238
- Locations
- 1
- Primary Endpoint
- To evaluate germline genetic variants and their association with lung cancer in never smokers.
- Status
- Active, not recruiting
- Last Updated
- 10 months ago
Overview
Brief Summary
The purpose of this study is to help us better understand the cellular changes that may lead to the development of lung cancer. We want to compare people who have never smoked and yet have been diagnosed with lung cancer to never smokers who have not developed lung cancer. We hope to use the information obtained in this study as the basis for future studies and will not regard the results from this study as final.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Cases will be eligible for inclusion if:
- •They have been diagnosed with a lung cancer or have had previous surgical treatment for their lung cancer and have smoked fewer than 100 cigarettes in their lifetime, are/were not regular cigar or pipe smokers, and
- •They have had no prior chemotherapy or radiation treatment within the last year (Exception: genotyping analysis/screening can be performed on specimens from individuals who had chemo/radiation treatment within the last year as germline DNA will not be affected)
- •They speak and read English
- •They understand and agree to sign informed consent, and
- •They agree to give us a blood sample, and
- •They agree to complete the study questionnaire, and
- •They agree to have their pathology information reviewed by study personnel.
- •Controls will be eligible for inclusion if:
- •They have not been diagnosed with any type of cancer, exclusive of nonmelanoma skin cancer and have smoked fewer than 100 cigarettes in their lifetime, are/were not regular cigar or pipe smokers, and
Exclusion Criteria
- •Subjects who do not meet the inclusion criteria for either the case or control groups will not be eligible for this study.
- •All individuals who otherwise meet the eligibility requirements above, but who have had chemotherapy or radiation therapy within 1 year of evaluation will be excluded (Exception: genotyping analysis/screening can be performed on specimens from individuals who had chemo/radiation treatment within the last year as germline DNA will not be affected).
Outcomes
Primary Outcomes
To evaluate germline genetic variants and their association with lung cancer in never smokers.
Time Frame: conclusion of study
Secondary Outcomes
- To evaluate whether overall DNA damage/repair capacity is associated with lung cancer in never smokers.(conclusion of study)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
DNA Repair and Genetic Susceptibility to Lung CancerLung CancerSingle Primary Lung CancerSecond Primary Lung CancerNCT00611598Memorial Sloan Kettering Cancer Center218
Recruiting
Not Applicable
Detection of Genetic Markers of Lung CancerLung CancerNCT00280202University of Pittsburgh6,000
Completed
Not Applicable
Risk Communication in African American SmokersLung CancerNCT04084561Temple University166
Completed
Phase 2
Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryLung CancerNCT00057798Roswell Park Cancer Institute21
Completed
Not Applicable
Genetic Epidemiology of Lung CancerLung CancerNCT00341835National Human Genome Research Institute (NHGRI)6,356